The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences

The COVID-19 pandemic has led to the biggest global health crisis of our lifetime. There is accumulating evidence that a substantial number of critically ill COVID-19 patients exhibit a dysregulated host response manifesting as cytokine storm or cytokine release syndrome, which in turn contributes t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz-Rodríguez, Juan Carlos, Molnar, Zsolt, Deliargyris, Efthymios N., Ferrer, Ricard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324379/
https://www.ncbi.nlm.nih.gov/pubmed/34336280
http://dx.doi.org/10.1155/2021/7769516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324379/
https://www.ncbi.nlm.nih.gov/pubmed/34336280
http://dx.doi.org/10.1155/2021/7769516

Ejemplares similares